Effects of oxyphenamone on myocardial ischemia in cats and rats

Yaoxue Xuebao

Volumn 40, Issue 2, 2005, Pages 122-126

  Fan, Li Li ^a   Ma, Jun ^a   Wang, Ya Fang ^a   Ruan, Ying Mao ^b   Zeng, Xian Ke ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Cardiac hemodynamics; Isoproterenol; Myocardial enzymes; Myocardial infarction; Myocardial pathology; Oxyphenamone

Indexed keywords

ALDEHYDE DERIVATIVE; ASPARTATE AMINOTRANSFERASE; CARDIOVASCULAR AGENT; CREATINE KINASE; ISOPRENALINE; OXYPHENAMONE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY OCCLUSION; ARTICLE; CAT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTROMAGNETIC FLOWMETER; HEART HEMODYNAMICS; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART RATE; HEART WORK; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MEAN ARTERIAL PRESSURE; MULTICHANNEL RECORDER; NONHUMAN; RAT; RECORDING; VASCULAR RESISTANCE;

ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; CARDIOTONIC AGENTS; CATS; HEART; HEART RATE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; ORGANIC CHEMICALS; RATS; RATS, WISTAR; VASODILATOR AGENTS;

EID: 15944394080     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Chen ZJ, Gao RL. Coronary Heart Diseases [M]. Beijing: People's Medical Publishing House, 2002. 571-608.
2. Shao GX, Fan LL, Mo RY, et al. The preparation for the compounds of amino-ketone [J]. Patent Gazette, 1991,7(8):27.
3. Fan LL, Sun LH, Lin Y. Effect of oxyphenamone, a new inodilator, on isolated cardiac muscles and arteries [J]. Acta Pharm Sin, 1997,32(11):808-812.
4. Fan LL, Sun LH, Li J. Effect of oxyphenamone, a new inodilator, on cardiac hemodynamics in normal rat, cat and dog [J]. Acta Pharm Sin, 1997,32 (10):744-749.
5. Fan LL, Sun LH, Sun ZQ, et al. Therapeutic effect of a novel inodilator oxyphenamone on experimental heart failure induced by sodium pentobarbital [J]. Acta Pharm Sin, 1999,34(2):103-108.
6. Fan LL, O' Keefe DD, Powell WW Jr. Pharmacologic studies on radix puerariae: effects of puerarin on regional myocardial blood flow and cardiac hemodynamics in dogs with acute myocardial ischemia [J]. Chin Med J (Engl), 1985,98(11):821-832.
7. 2+-sensitizers for the treatment of heart failure [J]. Curr Opin Crit Care, 2003,9(5):337-344.
8. Rump AFE, Acar D, Rosen R, et al. Functional and antiischaemic effects of the phosphodiesterase inhibitor levosimendan in isolated rabbit hearts [J]. Pharmacol Toxicol, 1994,74(2):244-248.
9. Lilleberg J, Nieminen MS, Akkila J, et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting [J]. Eur Heart J, 1998,19(4):660-668.
10. Moiseyev VS, Poder P, Andrejevs N, et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction [J]. Eur Heart J, 2002,23(18): 1422-1432.
11. Ye YX, Fan LL, Lin Y, et al. Biochemical mechanism of the positive inotropic effect of oxyphenamone [J]. Acta Pharm Sin, 1999,34(2):90-94.
12. 2+ affinity of cardiac troponin [J]. Acta Pharm Sin, 1999,34(9):658-661.
13. Fan LL, Sun ZQ, Song Z, et al. Effect of oxyphenamone on the physiological characteristics of myocardium and the concentration of intracelular free calcium [J]. Chin Pharm J, 2005, in press.
14. Fan LL, Song Z, Wang TY. Effect of oxyphenamone on sodium and calcium channels of guinea pig myocardial cells [J]. Acta Pharm Sin, 2004,39(6): 410-414.